Brainomix Deploys AI Imaging Platform Across West Virginia University Health System Network

Key Takeaways

• AI platform installed at all 25 WVU health sites.
• Real‑time imaging analysis speeds stroke diagnosis decisions.
• Standardizes assessments, reducing interpretation variability.
• Supports transfer decisions to specialist stroke centers.
• Enhances telestroke services, expanding expert care regionally.

Summary

Brainomix has rolled out its AI imaging platform, Brainomix 360 Stroke, to all 25 sites in the West Virginia University Health System. The tool provides real‑time, automated analysis of stroke scans, helping clinicians decide on treatment and transfer. The deployment aims to standardize imaging interpretation, reduce variability, and speed up care across academic and community hospitals. The partnership is positioned as a model for scalable AI‑driven stroke care.

Pulse Analysis

Artificial intelligence is reshaping acute stroke care by delivering instant, quantitative insights that were previously limited to specialist radiologists. Brainomix 360 Stroke leverages deep‑learning algorithms to automatically segment infarct core, penumbra, and vessel occlusions, enabling clinicians to make evidence‑based decisions within minutes. As hospitals nationwide grapple with staffing shortages and increasing imaging volumes, such AI platforms provide a scalable solution that maintains diagnostic quality while accelerating time‑critical interventions.

For health systems like WVU, network‑wide adoption of AI imaging creates operational efficiencies beyond faster reads. Standardized outputs reduce inter‑observer variability, streamline telestroke consultations, and inform transfer protocols to comprehensive stroke centers. By embedding the technology into existing workflows, the system can prioritize large‑vessel occlusions, cut door‑to‑needle times, and potentially lower overall costs associated with delayed treatment and prolonged hospital stays. Moreover, equitable access to expert‑level assessment helps bridge gaps between flagship academic hospitals and rural community sites.

The WVU rollout signals a broader industry shift toward integrated AI ecosystems that combine imaging, electronic health records, and decision‑support tools. As reimbursement models evolve to reward outcome‑based care, hospitals that demonstrate measurable improvements in stroke metrics will gain competitive advantage. Future iterations may incorporate multimodal data—such as perfusion imaging and clinical scores—to further refine patient selection for emerging therapies. WVU’s experience offers a replicable blueprint for other multi‑site networks seeking to harness AI for consistent, high‑quality stroke care.